Literature DB >> 16501088

Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus.

Philip Meuleman1, Louis Libbrecht, Stefan Wieland, Rita De Vos, Nagy Habib, Anna Kramvis, Tania Roskams, Geert Leroux-Roels.   

Abstract

It is generally accepted that the host's immune response rather than the virus itself is causing the hepatocellular damage seen in acute and chronic hepatitis B virus (HBV) infections. However, in situations of severe immune suppression, chronic HBV patients may develop a considerable degree of liver disease. To examine whether HBV has direct cytopathic effects in severely immune compromised hosts, we have infected severe combined immune deficient mice (uPA-SCID), harboring human liver cells, with HBV. Serologic analysis of the plasma of HBV-infected animals revealed the presence of extremely high amounts of viral genomes and proteins. Histological analysis of the livers of uPA-SCID chimeras infected with HBV for more than 2 months showed that the majority of human hepatocytes had a ground-glass appearance, stained intensely for viral proteins, and showed signs of considerable damage and cell death. This histopathologic pattern closely resembles the picture observed in the livers of immunosuppressed HBV patients. These lesions were not observed in animals infected with HBV for less than 1 month. Ultrastructural analysis of long-term-infected hepatocytes showed a highly increased presence of cylindrical HBsAg structures, core particles, and Dane particles compared to short-term-infected hepatocytes. These long-term-infected hepatocytes also contained elevated amounts of HBV cccDNA. In conclusion, HBV causes dramatic intracellular changes and hepatocellular damage in the human hepatocytes that reside in a severely immune deficient mouse. These lesions show much resemblance to the ones encountered in immunosuppressed chronic HBV patients. Our observations indicate that HBV may be directly cytopathic in conditions of severe immune suppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501088      PMCID: PMC1395427          DOI: 10.1128/JVI.80.6.2797-2807.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay.

Authors:  Matsuo Deguchi; Naoko Yamashita; Masanori Kagita; Seishi Asari; Yoshinori Iwatani; Takahiko Tsuchida; Kazushige Iinuma; Isa K Mushahwar
Journal:  J Virol Methods       Date:  2004-02       Impact factor: 2.014

2.  Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors.

Authors:  A E Wennerberg; M A Nalesnik; W B Coleman
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

3.  Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene.

Authors:  E P Sandgren; R D Palmiter; J L Heckel; C C Daugherty; R L Brinster; J L Degen
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

4.  Replacement of diseased mouse liver by hepatic cell transplantation.

Authors:  J A Rhim; E P Sandgren; J L Degen; R D Palmiter; R L Brinster
Journal:  Science       Date:  1994-02-25       Impact factor: 47.728

5.  Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa.

Authors:  Gerald C Kimbi; Anna Kramvis; Michael C Kew
Journal:  J Gen Virol       Date:  2004-05       Impact factor: 3.891

6.  High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis.

Authors:  J Y Lau; V G Bain; S E Davies; J G O'Grady; A Alberti; G J Alexander; R Williams
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

7.  Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees.

Authors:  Stefan F Wieland; Hans Christian Spangenberg; Robert Thimme; Robert H Purcell; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-05       Impact factor: 11.205

8.  Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation.

Authors:  K G Benner; R G Lee; E B Keeffe; R R Lopez; A W Sasaki; C W Pinson
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

9.  Progenitor cell activation in chronic viralhepatitis.

Authors:  Anastasia Fotiadu; Valentini Tzioufa; Eleni Vrettou; Dimitrios Koufogiannis; Constantine S Papadimitriou; Prodromos Hytiroglou
Journal:  Liver Int       Date:  2004-06       Impact factor: 5.828

10.  Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis.

Authors:  A L Mason; M Wick; H M White; K G Benner; R G Lee; F Regenstein; C A Riely; V G Bain; C Campbell; R P Perrillo
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682

View more
  22 in total

1.  Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

Authors:  Karl-Dimiter Bissig; Stefan F Wieland; Phu Tran; Masanori Isogawa; Tam T Le; Francis V Chisari; Inder M Verma
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

Review 2.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 3.  Hepatitis B virus large surface protein: function and fame.

Authors:  Yuri Churin; Martin Roderfeld; Elke Roeb
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

4.  The regulation of proteins associated with the cytoskeleton by hepatitis B virus X protein during hepatocarcinogenesis.

Authors:  Fanyun Kong; Hongjuan You; Renxian Tang; Kuiyang Zheng
Journal:  Oncol Lett       Date:  2017-02-22       Impact factor: 2.967

5.  Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens.

Authors:  Nicolas Brezillon; Dina Kremsdorf; Mary C Weiss
Journal:  Dis Model Mech       Date:  2008 Sep-Oct       Impact factor: 5.758

Review 6.  Endoplasmic reticulum stress in disease pathogenesis.

Authors:  Jonathan H Lin; Peter Walter; T S Benedict Yen
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

Review 7.  Animal models for the study of HCV.

Authors:  Koen Vercauteren; Ype P de Jong; Philip Meuleman
Journal:  Curr Opin Virol       Date:  2015-05-23       Impact factor: 7.090

Review 8.  HBV culture and infectious systems.

Authors:  C Nelson Hayes; Kazuaki Chayama
Journal:  Hepatol Int       Date:  2016-03-02       Impact factor: 6.047

9.  Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen.

Authors:  Ian Baudi; Masanori Isogawa; Federica Moalli; Masaya Onishi; Keigo Kawashima; Yuji Ishida; Chise Tateno; Yusuke Sato; Hideyoshi Harashima; Hiroyasu Ito; Tetsuya Ishikawa; Takaji Wakita; Matteo Iannacone; Yasuhito Tanaka
Journal:  PLoS Pathog       Date:  2021-05-12       Impact factor: 6.823

10.  HCV animal models: a journey of more than 30 years.

Authors:  Philip Meuleman; Geert Leroux-Roels
Journal:  Viruses       Date:  2009-09-02       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.